Market Snapshot

BSE Sensex: 73088.33 0.83%
BSE 500: 32199.48 0.32%
BSE 200: 10088.94 0.39%
BSE 100: 23199.58 0.55%
BSE Mid-Cap: 40004.52 -0.39%
BSE Small-Cap: 45433.79 -0.04%
BANKEX: 53720.76 1.02%
BSE IT Sector: 34139.78 -0.56%
Nifty 50: 22147 0.69%
Nifty 500: 20385.2 0.30%
Nifty 200: 12325.85 0.35%
Nifty 100: 22859.8 0.53%
Nifty Midcap 100: 48696.95 -0.61%
Nifty Small 100: 16270.4 -0.10%
Nifty IT: 33368.3 -0.39%
Nifty PSU Bank: 6933.25 -0.29%

News:

HDFC AMC Q4 PAT climbs 44% YoY...
Wipro Q4 PAT rises 5% QoQ to R...
Premier Explosives gains as bo...
Hindustan Zinc slides after Q4...
Axis Bank board to mull fund r...

Ind-Swift Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

19 Apr 2024 | 03:59 PM

118.43

1.95 (1.67%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

79.44%

Return (1Y)

Beaten S&P BSE Sensex by 56.74%
More Volatile

3.58%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 2.95%
Consistent Performer

9/12

Months

beaten S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

138

News & Announcements

Ind-Swift Laboratories consolidated net profit declines 29.38% in the December 2023 quarter
66 days ago

Ind-Swift Laboratories consolidated net profit declines 29.38% in the December 2023 quarter

13 - Feb - 2024 12:00 AM | 66 days ago

Net profit of Ind-Swift Laboratories declined 29.38% to Rs 19.42 crore in the quarter ended December 2023 as against Rs 27.50 crore during the previous quarter ended December 2022. Sales declined 8.05% to Rs 287.51 crore in the quarter ended December 2023 as against Rs 312.69 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 287.51 312.69 -8
OPM % 17.98 17.19 -
PBDT 37.75 39.74 -5
PBT 24.19 24.35 -1
NP 19.42 27.50 -29
Powered by Capital Market - Live News
Ind-Swift Laboratories to table results
80 days ago

Ind-Swift Laboratories to table results

30 - Jan - 2024 12:00 AM | 80 days ago

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 2024.
Powered by Capital Market - Live News
Ind-Swift Laboratories consolidated net profit rises 24.94% in the September 2023 quarter
111 days ago

Ind-Swift Laboratories consolidated net profit rises 24.94% in the September 2023 quarter

30 - Dec - 2023 12:00 AM | 111 days ago

Net profit of Ind-Swift Laboratories rose 24.94% to Rs 31.66 crore in the quarter ended September 2023 as against Rs 25.34 crore during the previous quarter ended September 2022. Sales declined 6.61% to Rs 289.71 crore in the quarter ended September 2023 as against Rs 310.21 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 289.71 310.21 -7
OPM % 22.67 18.94 -
PBDT 51.95 42.32 23
PBT 38.77 25.91 50
NP 31.66 25.34 25
Powered by Capital Market - Live News
Ind-Swift Laboratories standalone net profit rises 25.31% in the September 2023 quarter
164 days ago

Ind-Swift Laboratories standalone net profit rises 25.31% in the September 2023 quarter

07 - Nov - 2023 12:00 AM | 164 days ago

Net profit of Ind-Swift Laboratories rose 25.31% to Rs 30.10 crore in the quarter ended September 2023 as against Rs 24.02 crore during the previous quarter ended September 2022. Sales declined 6.00% to Rs 270.30 crore in the quarter ended September 2023 as against Rs 287.55 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 270.30 287.55 -6
OPM % 23.46 19.77 -
PBDT 49.67 40.41 23
PBT 36.48 24.02 52
NP 30.10 24.02 25
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Ind-Swift Laboratories Ltd has increased by 79.09% since past 3 Months
FII shareholding in Ind-Swift Laboratories Ltd has increased by 727.06% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	287.51	312.69	-8
OPM %	17.98	17.19	-
PBDT	37.75	39.74	-5
PBT	24.19	24.35	-1
NP	19.42	27.50	-29

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	289.71	310.21	-7
OPM %	22.67	18.94	-
PBDT	51.95	42.32	23
PBT	38.77	25.91	50
NP	31.66	25.34	25

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	270.30	287.55	-6
OPM %	23.46	19.77	-
PBDT	49.67	40.41	23
PBT	36.48	24.02	52
NP	30.10	24.02	25

General Notifications

My Notifications

Research Notifications

Ind-Swift Laboratories Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

118.43 1.95 (1.67%)

News & Announcements

Price vs Volume

Stock Trivia

Ind-Swift Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

118.43

1.95 (1.67%)